Authors:
GLUECK CJ
BELL H
VADLAMANI L
GUPTA A
FONTAINE RN
WANG P
STROOP D
GRUPPO R
Citation: Cj. Glueck et al., THE MUTANT FACTOR-V-LEIDEN GENE, 4G 4G POLYMORPHISM OF THE PLASMINOGEN-ACTIVATOR INHIBITOR GENE (PAI-1), HIGH LP(A), AND PAI-LP(A) INTERACTIONS - COMMON HERITABLE THROMBOPHILIC AND HYPOFIBRINOLYTIC PATHOETIOLOGIES OF RETINAL VEIN OCCLUSION/, Journal of investigative medicine, 46(7), 1998, pp. 254-254
Authors:
VADLAMANI L
GLUECK CJ
BELL H
GUPTA A
FONTAINE RN
WANG P
TRACY T
STROOP D
GRUPPO R
Citation: L. Vadlamani et al., HERITABLE THROMBOPHILIA AND HYPOFIBRINOLYSIS - COMMON PATHOETIOLOGIESOF RETINAL VEIN-THROMBOSIS, Journal of investigative medicine, 46(3), 1998, pp. 214-214
Authors:
GLUECK CJ
FREIBERG RA
GRUPPO R
KIRK P
FONTAINE R
GUPTA A
TRACY T
WANG P
Citation: Cj. Glueck et al., AMELIORATION OF OSTEONECROSIS BY TREATMENT OF THROMBOPHILIA AND HYPOFIBRINOLYSIS, Journal of investigative medicine, 46(3), 1998, pp. 227-227
Authors:
BRANDT G
GRUPPO R
GLUECK CJ
STROOP D
BECKER A
PILLOW A
WANG P
Citation: G. Brandt et al., SENSITIVITY, SPECIFICITY AND PREDICTIVE VALUE OF MODIFIED ASSAYS FOR ACTIVATED PROTEIN-C RESISTANCE IN CHILDREN, Thrombosis and haemostasis, 79(3), 1998, pp. 567-570
Citation: R. Gruppo et al., LEGG-PERTHES-DISEASE IN 3 SIBLINGS, 2 HETEROZYGOUS AND ONE HOMOZYGOUSFOR THE FACTOR-V-LEIDEN MUTATION, The Journal of pediatrics, 132(5), 1998, pp. 885-888
Authors:
GLUECK CJ
FREIBERG RA
CRAWFORD A
GRUPPO R
ROY D
TRACY T
SIEVESMITH L
WANG P
Citation: Cj. Glueck et al., SECONDHAND SMOKE, HYPOFIBRINOLYSIS, AND LEGG-PERTHES-DISEASE, Clinical orthopaedics and related research, (352), 1998, pp. 159-167
Authors:
GRUPPO R
GLUECK CG
BRANDT G
STROOP D
BECKER A
PILLOW A
WANG P
Citation: R. Gruppo et al., DETECTION OF THE FACTOR-V-LEIDEN GENE MUTATION IN CHILDREN - COMPARISON OF VARIOUS MODIFICATIONS OF THE FUNCTIONAL ACTIVATED PROTEIN-C RESISTANCE TEST, Thrombosis and haemostasis, 1997, pp. 69-69
Authors:
GRUPPO R
BRAY GL
SCHROTH P
PERRY M
GOMPERTS ED
Citation: R. Gruppo et al., SAFETY AND IMMUNOGENICITY OF RECOMBINANT FACTOR-VIII (RECOMBINATE(TM)) IN PREVIOUSLY UNTREATED PATIENTS (PUPS) - A 6.5-YEAR UPDATE, Thrombosis and haemostasis, 1997, pp. 663-663
Authors:
GLUECK CJ
MCMAHON RE
BOUQUOT JE
TRIPLETT D
GRUPPO R
WANG P
Citation: Cj. Glueck et al., HETEROZYGOSITY FOR THE LEIDEN MUTATION OF THE FACTOR-V GENE, A COMMONPATHOETIOLOGY FOR OSTEONECROSIS OF THE JAW, WITH THROMBOPHILIA AUGMENTED BY EXOGENOUS ESTROGENS, The Journal of laboratory and clinical medicine, 130(5), 1997, pp. 540-543
Authors:
GLUECK CJ
BRANDT G
GRUPPO R
CRAWFORD A
ROY D
TRACY T
STROOP D
WANG P
BECKER A
Citation: Cj. Glueck et al., RESISTANCE TO ACTIVATED PROTEIN-C AND LEGG-PERTHES-DISEASE, Clinical orthopaedics and related research, (338), 1997, pp. 139-152
Authors:
GLUECK CJ
STEVENS D
FREIBERG R
TRACY T
GRUPPO R
WANG P
Citation: Cj. Glueck et al., THROMBOPHILIA AND HYPOFIBRINOLYSIS - PATHOPHYSIOLOGIC CAUSES OF LEGG-PERTHES DISEASE, Journal of investigative medicine, 44(3), 1996, pp. 213-213
Authors:
GLUECK CJ
EDLIN P
SAFDI M
GOLDBERG S
TRACY T
GRUPPO R
Citation: Cj. Glueck et al., THROMBOPHILIA AND HYPOFIBRINOLYSIS - PATHOETIOLOGIES OF CROHNS-DISEASE, Journal of investigative medicine, 44(3), 1996, pp. 303-303
Authors:
GLUECK CJ
MCMAHON R
BOUQUOT J
TRACY T
GRUPPO R
WANG P
Citation: Cj. Glueck et al., THROMBOPHILIA AND HYPOFIBRINOLYSIS - PATHOPHYSIOLOGIC CAUSES OF OSTEONECROSIS OF THE JAWS, Journal of investigative medicine, 44(3), 1996, pp. 328-328
Authors:
GRUPPO R
GLUECK CJ
MCMAHON RE
BOUQUOT J
RABINOVICH BA
BECKER A
TRACY T
WANG P
Citation: R. Gruppo et al., THE PATHOPHYSIOLOGY OF ALVEOLAR OSTEONECROSIS OF THE JAW - ANTICARDIOLIPIN ANTIBODIES, THROMBOPHILIA, AND HYPOFIBRINOLYSIS, The Journal of laboratory and clinical medicine, 127(5), 1996, pp. 481-488
Authors:
GLUECK CJ
BRANDT G
GRUPPO R
CRAWFORD A
ROY D
BECKER A
TRACY T
STROOP D
Citation: Cj. Glueck et al., THROMBOPHILIA (RESISTANCE TO ACTIVATED PROTEIN-C, LOW PROTEIN-C OR PROTEIN-S) AND HYPOFIBRINOLYSIS CAUSING LEGG-PERTHES-DISEASE, Thrombosis and haemostasis, 73(6), 1995, pp. 1362-1362
Authors:
GLUECK CJ
BRANDT G
GRUPPO R
CRAWFORD A
ROY D
BECKER A
TRACY T
STROOP D
Citation: Cj. Glueck et al., FAMILIAL RESISTANCE TO ACTIVATED PROTEIN-C CAUSING LEGG-PERTHES DISEASE, Thrombosis and haemostasis, 73(6), 1995, pp. 1367-1367
Authors:
GRUPPO R
BRAY GL
SCHROTH P
GOMPERTS ED
ALEDORT L
Citation: R. Gruppo et al., TRANSIENT INHIBITORS IN RECIPIENTS OF RECOMBINANT FACTOR-VIII (R-FVIII) - A REPORT FROM THE RECOMBINATE(TM) STUDY OF PREVIOUSLY UNTREATED PATIENTS (PUPS), Blood, 86(10), 1995, pp. 758-758
Authors:
SOMMER SS
KETTERLING RP
VIELHABER E
SCHAID DJ
KASPER CK
PHILLIPS JA
KOERPER MA
KIM H
SEXAUER C
GRUPPO R
AMBRIZ R
PEREDES R
Citation: Ss. Sommer et al., GERMLINE ORIGINS IN THE HUMAN FACTOR-IX GENE - FREQUENT SOMATIC MOSAICISM WITH G-C-]A-T AND INCREASED MUTATIONS WITH ADVANCES MATERNAL AGE, Blood, 86(10), 1995, pp. 2433-2433
Authors:
BRAY GL
GOMPERTS ED
COURTER S
GRUPPO R
GORDON EM
MANCOJOHNSON M
SHAPIRO A
SCHEIBEL E
WHITE G
LEE M
GORDON M
BERTALONE S
LIPTON R
HILGARTNER M
ARKIN S
GILL J
KIM H
SHURIN S
SANTIAGOBORRERO P
ARKEL YS
KULKARNI R
GREENWOOD MF
RITCHEY AK
WERNER E
HAIRE WD
KISKER T
NEUFELD E
EWENSTEIN B
DEBIASI R
LAURIAN Y
KREUZ W
RODEGHIERO F
INGERSLEV J
GAZENGEL C
DIMICHELE D
COOPER H
Citation: Gl. Bray et al., A MULTICENTER STUDY OF RECOMBINANT FACTOR-VIII (RECOMBINATE) - SAFETY, EFFICACY, AND INHIBITOR RISK IN PREVIOUSLY UNTREATED PATIENTS WITH HEMOPHILIA-A, Blood, 83(9), 1994, pp. 2428-2435
Authors:
MIKHAEL A
STEELE PE
KHALILY M
HAKE D
LEE S
LAMPKIN B
GRUPPO R
SCHUMACHER H
Citation: A. Mikhael et al., DETECTION OF TERMINAL DEOXYNUCLEOTIDYL TRANSFERASE (TDT) MESSENGER-RNA IN CHILDHOOD LEUKEMIAS, Blood, 82(10), 1993, pp. 10000051-10000051